Arkolith/Insider Trading/CLSD/Form 4

Gibney Anthony S

DirectorClearside Biomedical, Inc. (CLSD) · full profile →Form 4 · filed Apr 19, 2024
Net Buying
Open-Market Buys
$130K
Open-Market Sells
$0
Net Open-Market Flow
$130K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 18, 2024Buy(P)93K$1.30$121K100K
Apr 17, 2024Buy(P)7K$1.25$8K7K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-011199) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML